Elisabeth Sivy Nginamau

Elisabeth Sivy Nginamau is an Associate Professor at the University of Oslo's Faculty of Medicine, affiliated with the Division of Diagnostics and Technology at Akershus University Hospital. Her research bridges clinical pathology, oncology, and diagnostic innovation, with particular expertise in head/neck and gynecological cancers. She maintains active collaborations with international researchers across Sudan, Norway, and other regions.

Research Focus: Dr. Nginamau's work centers on translational oncology, emphasizing:

• Identification of prognostic biomarkers (e.g., PD-L1, TP53, microRNAs) in oral and vulvar carcinomas
• Development of novel diagnostic tools like electronic nose technology for cancer detection
• Characterization of tumor microenvironment components including immune infiltrates and microbiome interactions
• Validation of histopathological scoring systems for improved cancer grading and reporting

Publication Analysis: Her recent work (2020-2023) demonstrates a strong focus on squamous cell carcinomas, with themes including biomarker discovery, diagnostic technology validation, and cancer microenvironment analysis. Earlier publications (2007-2011) explored autoimmune proteomics in Sjögren's syndrome, reflecting an interdisciplinary background.

Collaborative Networks: Dr. Nginamau consistently publishes with large multi-institutional teams, including researchers from Sudan, Norway, and other countries. She is integrated within the Division of Diagnostics and Technology, which supports her work in pathology innovation.